Hypothalamic mTOR signaling mediates the orexigenic action of ghrelin.
Current evidence suggests that ghrelin, a stomach derived peptide, exerts its orexigenic action through specific modulation of Sirtuin1 (SIRT1)/p53 and AMP-activated protein kinase (AMPK) pathways, which ultimately increase the expression of agouti-related protein (AgRP) and neuropeptide Y (NPY) in...
Guardado en:
Autores principales: | Luís Martins, Diana Fernández-Mallo, Marta G Novelle, María J Vázquez, Manuel Tena-Sempere, Rubén Nogueiras, Miguel López, Carlos Diéguez |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ee0d34b46e7b4b5c856607bd07fa97d9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanotechnology-Based Targeting of mTOR Signaling in Cancer
por: Yoon MS
Publicado: (2020) -
Fine-Tuning of mTOR mRNA and Nucleolin Complexes by SMN
por: Francesca Gabanella, et al.
Publicado: (2021) -
The mTOR pathway is necessary for survival of mice with short telomeres
por: Iole Ferrara-Romeo, et al.
Publicado: (2020) -
mTOR-dependent phosphorylation controls TFEB nuclear export
por: Gennaro Napolitano, et al.
Publicado: (2018) -
Activity-independent targeting of mTOR to lysosomes in primary osteoclasts
por: Andrew Wang, et al.
Publicado: (2017)